Peer Review History
| Original SubmissionOctober 16, 2020 |
|---|
|
PONE-D-20-32536 Stunting at birth and associated factors among newborns delivered at the University of Gondar Comprehensive Specialized Referral Hospital. PLOS ONE Dear Dr. Gonete, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. This is an interesting and largely well-written study. The reviewers have suggested a number of revisions that need to be made, all of which are important, which I will not add to. I look forward to receiving a revised version of the manuscript. Please submit your revised manuscript by Jan 31 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Clive J Petry, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide citations for the literature used to develop the survey, and describe how the newly constructed survey was validated. 3. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. If the original language is written in non-Latin characters, for example Amharic, Chinese, or Korean, please use a file format that ensures these characters are visible. 4. Please amend your current ethics statement to address the following concerns: Please explain why written consent was not obtained, how you recorded/documented participant consent, and if the ethics committees/IRBs approved this consent procedure. 5. Thank you for stating the following in the Acknowledgments Section of your manuscript: "The University of Gondar sponsored the study, however, the funder didn’t have a role in the study" We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "yes, but the funder has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript" Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 6. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 7. Please include a copy of Table 3 which you refer to in your text on page 15. 8. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 4 in your text; if accepted, production will need this reference to link the reader to the Table. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Comments_1: Authors wrote unnecessarily a lot about background profile of the study, please make it short, simple and precise. Comments_2: Are you sure no studies were available that highlighted stunted children at age 0 months? As all DHS reports this group of children. Comments_3: Need a major revision in the Literature review section. Comments_4: Write ‘This’ instead of ‘The’ in line number 100. Comments_5: Specify the name of the region in line number 119. Comments_6: Methods section is too long to read. Authors could make it short by combining Data Collection tools and procedures, Data quality control and Data processing and analysis and removing redundant information. Comments_7: According to WHO when a baby is born before 28 weeks of gestational age then it is known as extremely preterm. Why did you exclude the extreme preterm newborns (born before 33 weeks of gestational age)? Comments_8: Give the reason(s) of excluding the newborns whose mothers suffering from critical illness (postpartum hemorrhage) and newborns suffering from an illness (birth trauma)? Would these factors be not the reason for the stunting at birth? Comments_9: Did the authors or institution collect the data? Comments_10: Was the data primary or secondary? Make it clear. Comments_11: What was your actual study period? It’s confusing, as your data collection period and study period is different. Comments_12: What was the actual sample size? In method section it isn’t clearly stated. In abstract it is 422, but in result section it is 419. So this is puzzling. Comments_13: Mention the year beside the months in line 141. Comments_14: In line 196, the authors described about wealth index. But in the Data processing and analysis section they again described about income status of mothers is a bit confusing. Comments_15: The lines 242 and 243 are confusing, why fisher exact test was performed. Comments_16: Give an acceptance/rejection range for Variance Inflation Factor (VIF) in line 246. Comments_17: VIF is used to assess the multicollinearity for multiple linear regression analysis. How it works for multiple logistic regressions analyses please explain. Comments_18: You should display the results of all the study variables using tables, graphs, charts, or figures. Comments_19: In table 1, specify the age range (beside the categories) of the mothers. Comments_20: Use the table/figures to represent the Maternal Characteristics and Environmental characteristics of the newborns. Comments_21: Change the table number in line 383. Comments_22: Add an extra column in table 3 to indicate the p-values. Comments_23: Add the meaning of ‘1’ in notes section under the table 3. Comments_24: In line 405, you said that the overall stunting at birth was 41.7 % (37% - 46.7%). What’s the basis of this statement? Is this your findings? Comments_25: As income is not associated with the stunting then why authors made the recommendation. Comments_26: It is pretty obvious that malnourished mothers will give low birth weight children in most cases that causes stunting/malnutrition among new born and the findings showed high correlation why authors tried to justify this findings? Comments_27: Policy recommendation is missing in this study. Comments_28: Provide a list of abbreviation. Comments_29: Add the reference(s) in line number 71, 89, 91, 97, 124, 126, 140, 197, 226, 227, 249, and 420. Comments_30: Correctly cite the reference in line number 127. Reviewer #2: Explanation for the Q number: 3. The data about low birth weight was not presented. only small for gestational age (SGA), that's not the same with low birth weight. There are some variables that are not described in the operational definition/objective criteria: - classification of the mother's age - Intention of pregnancy - malnourished mother (what criteria that was used for determining malnourished; MUAC?, it should be described. - please consider the definition of stunting at birth, because the length of birth is associated with gestational age. The length <48 cm maybe only for a term newborn in general, while for preterm we have to look at the growth chart that we used. if the length for gestational age is appropriate, we cannot say that is stunted newborn. Preferably data on the mean or median birth length of the stunted newborn are presented. 4. The are several typing errors, and abbreviations that are not common (Px; pregnancy) Tables: it is not common to put the size of the samples (n) on the title of the table Discussions: Semarang is one of the city in Indonesia, so it cannot be written as two different cities or country. please check the citation. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Md. Shariful Islam, Lecturer, Dept. of Public Health, First Capital University of Bangladesh, Chuadanga, Khulna, Bangladesh Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Stunting at birth and associated factors among newborns delivered at the University of Gondar Comprehensive Specialized Referral Hospital. PONE-D-20-32536R1 Dear Dr. Gonete, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Clive J Petry, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-32536R1 Stunting at birth and associated factors among newborns delivered at the University of Gondar Comprehensive Specialized Referral Hospital. Dear Dr. Gonete: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Clive J Petry Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .